Log in to search using one of your social media accounts:

 

Cataract surgery in older women may reduce risk of death, study shows

New study reveals a longer life might be an unexpected benefit of cataract surgery, the most frequently performed operation in the U.S. A large study of women links the eye procedure to a 60 percent lower risk of dying from all causes. Dr. Christopher Starr, an ophthalmologist at Weill Cornell Medical Center, joins "CBS This Morning" to discuss the findings.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news

Related Links:

It was reported that lack of knowledge, less confidence of medical services, commute difficulties, and poor economic conditions would be the main barriers for cataract surgery practice. The influencing factors...
Source: BMC Ophthalmology - Category: Opthalmology Authors: Tags: Research article Source Type: research
ConclusionsTo the best of our knowledge, this method of demonstrating cold agglutinin disease has not been described in the literature and could easily be performed utilizing an ordinary slit lamp. This method could be used as an alternative and rapid screening method for cold agglutinin disease.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
Conditions:   Post-Op Complication;   Raised Ocular Pressure Intervention:   Procedure: Aqueous release of the wound Sponsor:   Bedford Hospital NHS Trust Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
This study looks at the viability of MIGS in patients who don’t need or may have already had cataract surgery, so it’s a vital addition to our growing body of evidence supporting MIGS,” Compare trial medical monitor Dr. Iqbal Ahmed said in a prepared release. Ivantis said the 152-patient trial was the first to compare two minimally invasive glaucoma surgery device for treating open-angle glaucoma in a standalone procedure. The study aimed to compare safety and effectiveness of both devices in lowering IOP and reducing eye-drop medication. Results at one year showed that 47% of eyes treated with the Hydrus...
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Optical/Ophthalmic Glaukos Ivantis Source Type: news
Glaukos (NYSE:GKOS) today released two-year data from the FDA investigational device exemption pivotal trial of its iStent inject trabecular micro-bypass system, and announced a patent infringement suit it filed against Ivantis. Results of the 505-patient study were presented at the American Society of Cataracts and Refractive Surgery annual meeting by Dr. Thomas Samuelson of the Minnesota Eye Consultants, the San Clemente, Calif.-based company said. The iStent inject trabecular micro-bypass system is designed to treat mild-to-moderate open-angle glaucoma in patients undergoing cataract surgery. It uses a pa...
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Optical/Ophthalmic Patent Infringement Glaukos Source Type: news
AbstractPurpose of reviewWe review the prevention and treatment of postoperative endophthalmitis.Recent findingsPostoperative endophthalmitis is rare but has potentially blinding consequences. There is no consensus on prevention, but there are a few controlled studies with methods of decreasing the infection rate, such as use of povidone iodine and intracameral antibiotics. There remains only one randomized controlled study (Endophthalmitis Vitrectomy Study or EVS) on the treatment of postoperative endophthalmitis, but there are retrospective studies which examine the timing and various methods of vitrectomy and intravitre...
Source: Current Ophthalmology Reports - Category: Opthalmology Source Type: research
Authors: Alnawaiseh M, Müller V, Lahme L, Merté RL, Eter N Abstract Purpose: To evaluate changes in flow density after the implantation of a trabecular microbypass stent (iStent) in combination with cataract surgery. Methods: A total of 48 eyes of 48 patients, who underwent either cataract surgery alone (cataract group) or cataract surgery with implantation of two iStent inject devices (iStent group), were prospectively included in this study. Intraocular pressure (IOP) and flow density data before and after surgery were extracted and analyzed. Results: In the iStent group, the mean IOP was 18.2...
Source: Journal of Ophthalmology - Category: Opthalmology Tags: J Ophthalmol Source Type: research
CONCLUSION: This is the first study using electronic Schiotz tonography with documented anterior chamber depth and gonioscopy after modern cataract surgery (CS) with phacoemulsification and IOL implantation. We demonstrated that phacoemulsification increases TOF and this fully accounts for the IOP reduction following CS. ISTCRN REGISTRATION NUMBER: ISRCTN04247738. PMID: 29654113 [PubMed - as supplied by publisher]
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Tags: Br J Ophthalmol Source Type: research
ConclusionsThe new MICS IOL provided excellent visual outcomes and was safe and effective for the sub-2-mm procedure. The MICS IOL demonstrated long-term centration, stability and a low rate of PCO development.
Source: International Ophthalmology - Category: Opthalmology Source Type: research
AbstractPurposeTo investigate alterations of corneal layers in eyes treated for acute postoperative endophthalmitis.MethodsIn this retrospective, nonrandomized comparative study, eyes treated with 25 gauge pars plana vitrectomy (PPV) for acute post-cataract endophthalmitis (group A) were compared to eyes receiving uneventful cataract surgery (group B) and uneventful 25 gauge PPV for epiretinal membrane (group C). After a minimum follow-up of 8  months from last surgical procedure, laser scanning in vivo confocal microscopy (IVCM) was performed.ResultsTwelve eyes for each group were recruited. Comparing study eyes with...
Source: International Ophthalmology - Category: Opthalmology Source Type: research
More News: Cataract Removal | Cataracts | Health | Opthalmology | Study | Women